Kidney Cancer Trial, Recruiting (NCT07294547)

Kidney Cancer Trial, Recruiting NCT07294547 Sponsor: National Taiwan University Hospital Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07294547 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 3 years or older
People who are about to receive a kidney transplant, or who received one within the past 2 weeks before the screening date
People whose transplant surgeon has decided they should receive preventive antiviral medication against CMV and/or EBV
People who do not currently have an active CMV or EBV infection in the blood (as measured by a virus detection test) at the time of screening
People (or, for children, their parent or legal guardian) who are willing and able to give consent and follow the study procedures

Who may not be able to join:

People with serious other health conditions that the transplant surgeon considers would make participation unsafe
People who are pregnant (one of the study medications, valganciclovir, is likely to cause harm to an unborn baby)
People who are known to be allergic to both valacyclovir and valganciclovir

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-2312-3456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07294547

Sponsor: National Taiwan University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: 886-2312-3456

More information: https://clinicaltrials.gov/study/NCT07294547

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 3 years or older
People who are about to receive a kidney transplant, or who received one within the past 2 weeks before the screening date
People whose transplant surgeon has decided they should receive preventive antiviral medication against CMV and/or EBV
People who do not currently have an active CMV or EBV infection in the blood (as measured by a virus detection test) at the time of screening
People (or, for children, their parent or legal guardian) who are willing and able to give consent and follow the study procedures

Who may not be able to join:

People with serious other health conditions that the transplant surgeon considers would make participation unsafe
People who are pregnant (one of the study medications, valganciclovir, is likely to cause harm to an unborn baby)
People who are known to be allergic to both valacyclovir and valganciclovir

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Taiwan University Hospital

Registry

ClinicalTrials.gov

Start date

27 November 2025

Est. completion

1 December 2029

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Time to new-onset CMV viremia; Time to new-onset EBV viremia; Cumulative incidence of new-onset CMV viremia; Cumulative incidence of new-onset EBV viremia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov